论文信息 - Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII? - 字舞流文

Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII?

M. Béné | L. Ardillon | Y. Gruel | M. Trossaërt | J. Valentin | C. Ternisien | M. Fouassier | M. Sigaud | B. Gillet | V. Horvais | Nicolas Drillaud | Jean-Baptiste Valentin

[1] C. Hermans,et al. VWF‐FVIII concentrates in the treatment of inherited von Willebrand disease: A single‐centre retrospective study , 2019, Haemophilia.

[2] Kenneth L. Jones,et al. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels. , 2017, Blood.

[3] D. Lillicrap. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. , 2013, Hematology. American Society of Hematology. Education Program.

[4] C. Casari,et al. von Willebrand factor: the old, the new and the unknown , 2012, Journal of thrombosis and haemostasis : JTH.

[5] P. James,et al. The prevalence of symptomatic von Willebrand disease in primary care practice , 2010, Journal of thrombosis and haemostasis : JTH.

[6] A. Tosetto,et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. , 2008, Blood.

[7] A. Federici. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007) , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[8] P. Mannucci,et al. Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus‐inactivation/removal methods , 2005, Journal of thrombosis and haemostasis : JTH.